Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-22-003419

Chief Financial Officer bought 1,923 shares at $6.75 ($12,980)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Broadfoot Jill Marie Chief Financial Officer 2022-01-13 Purchase +1,923 $6.75 $12,980 12,112 D
Open-market purchases · 1,923 sh · avg $6.75 · $12,980
Loading xslF345X03/doc4.xml…